ChemT Raises $4M Seed

ChemT, a Singapore-based biotechnology company providing AI-driven solutions for biomanufacturing, has raised $4 million in a Seed funding round. This latest injection of capital brings the company's total funding to $5 million since its founding 18 months ago.

Investors

The funding round was anchored by Wavemaker Ventures and SEEDS. Additional participating investors include Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator.

ChemT Use of Funds

ChemT intends to use the capital to expand its AI and experimental infrastructure, advance its AI-designed molecular products toward regulatory readiness, and grow its commercial partnerships. The company also plans to extend its CelMo platform capabilities to support stem cells, natural killer cells, and HEK cells.

About ChemT

Founded in 2024 by Jie Sun and Dr. Ling Wu, ChemT provides an AI-powered platform called CelMo, which acts as a virtual cell model. By simulating how cells respond to manufacturing conditions and genetic modifications, the company helps pharmaceutical manufacturers improve productivity and scalability in biologics production.

Funding Details

Company Website: https://chemtbio.com

Company: ChemT
Raised: $4M
Round: Seed
Funding Date: June 22, 2026
Lead Investor: Wavemaker Ventures, SEEDS
Additional Investors: Wavemaker 360 Health, Draper University Ventures, Temasek Life Sciences Accelerator
Software Category: Biotechnology / AI
Source: https://www.dealstreetasia.com/stories/chemt-raises-funds-biomanufacturing-486283